Published in Neurology on May 10, 2005
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol (2009) 4.55
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage (2007) 4.07
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage (2008) 3.74
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res (2009) 3.31
Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging (2006) 3.26
Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging (2010) 3.16
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage (2008) 2.36
Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp (2009) 2.24
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Biomarkers for early detection of Alzheimer pathology. Neurosignals (2007) 1.86
Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.63
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage (2009) 1.63
Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol (2009) 1.63
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage (2009) 1.55
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50
Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol (2008) 1.49
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging (2006) 1.36
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord (2009) 1.33
Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. AJNR Am J Neuroradiol (2009) 1.29
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain (2011) 1.23
Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging (2008) 1.23
Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc (2008) 1.20
Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol (2011) 1.20
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiol Aging (2010) 1.17
Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One (2013) 1.12
Biomarkers in translational research of Alzheimer's disease. Neuropharmacology (2010) 1.11
Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. Neuroimage (2010) 1.07
Changes in parahippocampal white matter integrity in amnestic mild cognitive impairment: a diffusion tensor imaging study. Behav Neurol (2009) 1.04
Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03
MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage (2012) 1.02
Noninvasive delivery of gene targeting probes to live brains for transcription MRI. FASEB J (2007) 0.99
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. J Alzheimers Dis (2010) 0.99
Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. J Alzheimers Dis (2011) 0.99
An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients. PLoS One (2011) 0.95
Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. Behav Neurol (2009) 0.93
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Alzheimers Dement (2013) 0.92
fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults. Dement Geriatr Cogn Disord (2008) 0.89
Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease. Neurobiol Aging (2010) 0.89
Entorhinal cortex structure and functional MRI response during an associative verbal memory task. Hum Brain Mapp (2009) 0.89
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia. Mov Disord (2012) 0.86
Magnetic resonance imaging of Alzheimer's disease. Eur Radiol (2006) 0.84
Age-related changes in parahippocampal white matter integrity: a diffusion tensor imaging study. Neuropsychologia (2012) 0.83
Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. Neuroimage (2010) 0.81
Event time analysis of longitudinal neuroimage data. Neuroimage (2014) 0.80
Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity. Int J Alzheimers Dis (2012) 0.80
Mild cognitive impairment. Continuum (Minneap Minn) (2013) 0.79
Age-related changes in the mesial temporal lobe: the parahippocampal white matter region. Neurobiol Aging (2011) 0.78
Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults. Neurobiol Aging (2014) 0.78
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review. BMC Geriatr (2016) 0.77
Brain imaging of mild cognitive impairment and Alzheimer's disease. Neural Regen Res (2013) 0.76
Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study. BMJ Open (2011) 0.76
APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus. Front Hum Neurosci (2016) 0.75
Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study. Neuroimage Clin (2017) 0.75
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease. Alzheimers Res Ther (2017) 0.75
Temporal lobe anatomy: eight imaging signs to facilitate interpretation of MRI. Surg Radiol Anat (2015) 0.75
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers. J Alzheimers Dis (2017) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med (1999) 6.34
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging (2001) 4.54
Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology (2006) 3.71
Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Relation of cognitive activity to risk of developing Alzheimer disease. Neurology (2007) 3.34
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology (2000) 2.80
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
Neurodegenerative basis of age-related cognitive decline. Neurology (2010) 2.41
Chronic distress and incidence of mild cognitive impairment. Neurology (2007) 2.33
Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31
Parkinsonian signs in subjects with mild cognitive impairment. Neurology (2005) 2.30
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging (2004) 2.29
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Terminal decline in cognitive function. Neurology (2003) 2.18
Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology (2005) 2.13
Cognitive activity and cognitive decline in a biracial community population. Neurology (2003) 2.06
An on-line archive of reconstructed hippocampal neurons. J Neurosci Methods (1998) 2.03
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ (2000) 1.92
Gait pattern in the early recovery period after stroke. J Bone Joint Surg Am (1996) 1.88
Age-related loss of axospinous synapses formed by two afferent systems in the rat dentate gyrus as revealed by the unbiased stereological dissector technique. Hippocampus (1992) 1.85
Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology (2005) 1.70
Terminal dedifferentiation of cognitive abilities. Neurology (2012) 1.68
Memory complaints are related to Alzheimer disease pathology in older persons. Neurology (2006) 1.67
The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry (2002) 1.57
Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging (2006) 1.56
Body mass index in older persons is associated with Alzheimer disease pathology. Neurology (2006) 1.55
The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke (2005) 1.55
Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol (1999) 1.55
The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry (2006) 1.55
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology (2002) 1.54
Change in frailty and risk of death in older persons. Exp Aging Res (2009) 1.54
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology (1999) 1.47
Physical activity and motor decline in older persons. Muscle Nerve (2007) 1.45
Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging (2000) 1.44
Table-top ultrafast x-ray microcalorimeter spectrometry for molecular structure. Phys Rev Lett (2013) 1.44
From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci (2000) 1.44
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain (2012) 1.40
Computer simulations of morphologically reconstructed CA3 hippocampal neurons. J Neurophysiol (1995) 1.40
Severity of articular cartilage abnormality in patients with osteoarthritis: evaluation with fast spin-echo MR vs arthroscopy. AJR Am J Roentgenol (1994) 1.39
Blood conservation. Br J Anaesth (1991) 1.38
Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA (1997) 1.38
Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess (2006) 1.37
Prenatal dietary choline supplementation decreases the threshold for induction of long-term potentiation in young adult rats. J Neurophysiol (1998) 1.37
Steady-state electrotonic analysis of intracellularly stained hippocampal neurons. J Neurophysiol (1980) 1.36
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology (2008) 1.36
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology (2005) 1.34
Age and dose-dependent effects of ethanol on the induction of hippocampal long-term potentiation. Alcohol (1999) 1.34
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int (1996) 1.34
Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus (2000) 1.32
Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology (2003) 1.31
Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented postsynaptic densities. Brain Res (1991) 1.31
Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease. Psychol Med (2004) 1.30
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
State-specific projections through 2025 of Alzheimer disease prevalence. Neurology (2004) 1.29
African American antiplatelet stroke prevention study: Clinical trial design. J Stroke Cerebrovasc Dis (2007) 1.29
Structural synaptic correlate of long-term potentiation: formation of axospinous synapses with multiple, completely partitioned transmission zones. Hippocampus (1993) 1.27
Reactive astrocytes express the embryonic intermediate neurofilament nestin. Neuroreport (1994) 1.27
Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Arch Neurol (2000) 1.27
Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg (1995) 1.25
Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol (1999) 1.25
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol (1999) 1.25
Progression of gait disorder and rigidity and risk of death in older persons. Neurology (2002) 1.25
Gender, cognitive decline, and risk of AD in older persons. Neurology (2003) 1.25
MRI of human entorhinal cortex: a reliable protocol for volumetric measurement. Neurobiol Aging (2001) 1.24
CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther (1987) 1.24
Age-related alterations in potentiation in the CA1 region in F344 rats. Neurobiol Aging (1993) 1.24
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol (2000) 1.24
Advances in the prevention of Alzheimer's disease and dementia. J Intern Med (2014) 1.23
Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.23
Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging (2008) 1.23
Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ (1997) 1.22
Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology (2011) 1.22
Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 1.22
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol (2001) 1.22
Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging (1997) 1.21
Interaction between tissue oxygen tension and NADH imaging during synaptic stimulation and hypoxia in rat hippocampal slices. Neuroscience (2005) 1.21
Dendritic properties of hippocampal CA1 pyramidal neurons in the rat: intracellular staining in vivo and in vitro. J Comp Neurol (1998) 1.19
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology (2003) 1.19
"On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord (2000) 1.19
Rate of cognitive decline and mortality in Alzheimer's disease. Neurology (2003) 1.18
Interneurons of the dentate-hilus border of the rat dentate gyrus: morphological and electrophysiological heterogeneity. J Neurosci (1997) 1.18
Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology (2004) 1.17